Ultram tablet
For further information, please contact Ken Howling at 905-286-3000 or send inquiries to ir@biovail. Food and Drug Administration’s Approved Drug Products with Therapeutic Equivalence Evaluations database (commonly referred to as the Orange Book) in 2006. Forward-looking statements include, but are not necessarily limited to risks and uncertainties, including the difficulty of predicting FDA approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials and finished products, third parties, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the company’s filings with the Securities and Exchange Commission. A wholly ultram tablet owned subsidiary of IVAX Corporation (AMEX:IVX) (LSE:IVX. L) for ultram tablet able Labs’ Tramadol Hydrochloride Tablets. Tramadol is one of a number of analgesics, which are among the most effective medications for the treatment of chronic pain. Eon’s diverse product line includes over 90 generic pharmaceutical products. To the extent any statements made in this release contain information that is not historical, these statements are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E Ultram tablet of the Securities Exchange Act of 1934, as amended. Ultram’s 2001 sales reached $650 million. Teva USA introduced tramadol 50 mg hydrochloride tablets. Subject to FDA approval, Ultram tablet ralivia(tm) FlashDose(R) will be available in 50mg, tablets by prescription only. Safe Harbor statement under the Private Securities Litigation ultram tablet reform Act of 1995. Johnson Pharmaceutical Research Institute’s Ultram(R) Tablets which is indicated for the management of moderate to moderately severe pain. Approved to prevent organ rejection following liver transplantation. 17, 2002 Teva Pharmaceutical ultram tablet industries Ltd. Tramadol is used to treat persistent moderate to severe pain and is the generic equivalent of Ultram(R) tablets marketed by Johnson ultram tablet & Johnson. Tramadol is currently sold in the United States under the brand name Ultram(R) with approximately 11 million prescriptions dispensed during for the twelve months ended December 31, 2003 including generics. Further ultram tablet information on Able may be found on the Company’s web site, www. Ablelabs. Com Except for historical facts, the statements in this news release, as well as oral statements or other ultram tablet written statements made or to be made by Able Laboratories, Inc. , are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties.